碧迪医疗(Becton Dickinson) BDX
$211.88 −$1.67 (-0.78%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $211.88 0.00%
开盘$209.29
昨收$213.55
当日区间$208.95 – $214.88
成交量2.17M
市值$57.71B
市盈率（TTM）51.8
股息率1.98%
财报
财报日平均波动±5.1%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+8.9%
最差反应-18.1%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 6 Aug 2026 | Pre Market | ±6.6% | +3.76% | 符合区间 |
| 2026/Q2 | 7 May 2026 | Pre Market | ±5.2% | +5.87% | 超出定价预期 |
| 2026/Q1 | 9 Feb 2026 | Pre Market | ±6.5% | -1.25% | 符合区间 |
| 2025/Q4 | 6 Nov 2025 | None | ±5.4% | +0.57% | 符合区间 |
| 2025/Q3 | 7 Aug 2025 | None | ±8.5% | +8.86% | 超出定价预期 |
| 2025/Q2 | 1 May 2025 | Pre Market | ±6.1% | -18.13% | 超出定价预期 |
| 2025/Q1 | 6 Feb 2025 | Pre Market | ±5.4% | -7.28% | 超出定价预期 |
| 2024/Q4 | 7 Nov 2024 | Pre Market | ±5.0% | -5.39% | 超出定价预期 |
| 2024/Q3 | 1 Aug 2024 | Pre Market | ±5.8% | -2.09% | 符合区间 |
| 2024/Q2 | 2 May 2024 | Pre Market | ±5.4% | +2.84% | 符合区间 |
| 2024/Q1 | 1 Feb 2024 | Pre Market | ±5.1% | +1.48% | 符合区间 |
| 2023/Q4 | 9 Nov 2023 | Pre Market | ±4.4% | -9.25% | 超出定价预期 |
| 2023/Q3 | 3 Aug 2023 | Pre Market | ±4.5% | -2.73% | 符合区间 |
| 2023/Q2 | 4 May 2023 | Pre Market | ±5.3% | -4.23% | 符合区间 |
| 2023/Q1 | 2 Feb 2023 | Pre Market | ±3.6% | -2.24% | 符合区间 |
| 2022/Q4 | 10 Nov 2022 | Pre Market | ±4.4% | +5.03% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q3 季度
按业务线
基本面
最新报告季度：Q3, ended Jun 2026
营收$4.98B+5.4% YoY
营业利润$752.00M-9.9% YoY
净利润$377.00M-34.3% YoY
摊薄每股收益$1.37-31.5% YoY
自由现金流$508.00M-51.9% YoY
经营现金流$651.00M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率46.9%
营业利润率14.5%
净利率4.2%
净资产收益率3.8%
资产收益率1.8%
投入资本回报率3.3%
流动比率0.87
负债/资产比率51.9%
现金及投资$709.00M
总负债$16.81B
净现金（净负债）-$16.10B
自由现金流/营收11.2%
暂无评论——快来第一个聊聊 BDX。
登录后参与讨论。